Biology Reference
In-Depth Information
19. Naldini L, Blomer U, Gage FH, Trono D,
Verma IM (1996) Effi cient transfer, integra-
tion, and sustained long-term expression of
the transgene in adult rat brains injected with
a lentiviral vector. Proc Natl Acad Sci USA
93:11382-11388
20. Naldini L, Blomer U, Gallay P, Ory D,
Mulligan R, Gage FH, Verma IM, Trono D
(1996) In vivo gene delivery and stable trans-
duction of nondividing cells by a lentiviral
vector. Science 272:263-267
21. Schlegel R, Tralka TS, Willingham MC,
Pastan I (1983) Inhibition of VSV binding
and infectivity by phosphatidylserine: is phos-
phatidylserine a VSV-binding site? Cell
32:639-646
22. Coil DA, Miller AD (2004) Phosphatidylserine
is not the cell surface receptor for vesicular
stomatitis virus. J Virol 78:10920-10926
23. Bloor S, Maelfait J, Krumbach R, Beyaert R,
Randow F (2010) Endoplasmic reticulum
chaperone gp96 is essential for infection with
vesicular stomatitis virus. Proc Natl Acad Sci
USA 107:6970-6975
24. Kordower JH, Bloch J, Ma SY, Chu Y, Palfi S,
Roitberg BZ, Emborg M, Hantraye P, Deglon
N, Aebischer P (1999) Lentiviral gene trans-
fer to the nonhuman primate brain. Exp
Neurol 160:1-16
25. Kordower JH, Emborg ME, Bloch J, Ma SY,
Chu Y, Leventhal L, McBride J, Chen EY, Palfi
S, Roitberg BZ, Brown WD, Holden JE,
Pyzalski R, Taylor MD, Carvey P, Ling Z,
Trono D, Hantraye P, Deglon N, Aebischer P
(2000) Neurodegeneration prevented by lenti-
viral vector delivery of GDNF in primate models
of Parkinson's disease. Science 290:767-773
26. Deglon N, Tseng JL, Bensadoun JC, Zurn
AD, Arsenijevic Y, Pereira de Almeida L,
Zufferey R, Trono D, Aebischer P (2000)
Self-inactivating lentiviral vectors with
enhanced transgene expression as potential
gene transfer system in Parkinson's disease.
Hum Gene Ther 11:179-190
27. de Almeida LP, Zala D, Aebischer P, Deglon
N (2001) Neuroprotective effect of a CNTF-
expressing lentiviral vector in the quinolinic
acid rat model of Huntington's disease.
Neurobiol Dis 8:433-446
28. Desmaris N, Bosch A, Salaun C, Petit C,
Prevost MC, Tordo N, Perrin P, Schwartz O,
de Rocquigny H, Heard JM (2001)
Production and neurotropism of lentivirus
vectors pseudotyped with lyssavirus envelope
glycoproteins. Mol Ther 4:149-156
29. Nathanson JL, Yanagawa Y, Obata K, Callaway
EM (2009) Preferential labeling of inhibitory
and excitatory cortical neurons by endogenous
tropism of adeno-associated virus and lentivi-
rus vectors. Neuroscience 161:441-450
30. Anliker B, Abel T, Kneissl S, Hlavaty J, Caputi
A, Brynza J, Schneider IC, Munch RC,
Petznek H, Kontermann RE, Koehl U,
Johnston IC, Keinanen K, Muller UC,
Hohenadl C, Monyer H, Cichutek K,
Buchholz CJ (2010) Specifi c gene transfer to
neurons, endothelial cells and hematopoietic
progenitors with lentiviral vectors. Nat
Methods 7:929-935
31. Cannon JR, Sew T, Montero L, Burton EA,
Greenamyre JT (2011) Pseudotype-
dependent lentiviral transduction of astro-
cytes or neurons in the rat substantia nigra.
Exp Neurol 228:41-52
32. Zala D, Bensadoun JC, Pereira de Almeida L,
Leavitt BR, Gutekunst CA, Aebischer P,
Hayden MR, Deglon N (2004) Long-term
lentiviral-mediated expression of ciliary neu-
rotrophic factor in the striatum of
Huntington's disease transgenic mice. Exp
Neurol 185:26-35
33. de Almeida LP, Ross CA, Zala D, Aebischer P,
Deglon N (2002) Lentiviral-mediated deliv-
ery of mutant huntingtin in the striatum of
rats induces a selective neuropathology mod-
ulated by polyglutamine repeat size, hunting-
tin expression levels, and protein length.
J Neurosci 22:3473-3483
34. Regulier E, Pereira de Almeida L, Sommer B,
Aebischer P, Deglon N (2002) Dose-
dependent neuroprotective effect of ciliary
neurotrophic factor delivered via tetracycline-
regulated lentiviral vectors in the quinolinic
acid rat model of Huntington's disease. Hum
Gene Ther 13:1981-1990
35. Runne H, Regulier E, Kuhn A, Zala D, Gokce
O, Perrin V, Sick B, Aebischer P, Deglon N,
Luthi-Carter R (2008) Dysregulation of
gene expression in primary neuron models
of Huntington's disease shows that
polyglutamine-related effects on the striatal
transcriptome may not be dependent on brain
circuitry. J Neurosci 28:9723-9731
36. Forman MS, Lal D, Zhang B, Dabir DV,
Swanson E, Lee VM, Trojanowski JQ (2005)
Transgenic mouse model of tau pathology in
astrocytes leading to nervous system degen-
eration. J Neurosci 25:3539-3550
37. Colin A, Faideau M, Dufour N, Auregan G,
Hassig R, Andrieu T, Brouillet E, Hantraye P,
Bonvento G, Deglon N (2009) Engineered
lentiviral vector targeting astrocytes in vivo.
Glia 57:667-679
38. Palfi S, Brouillet E, Jarraya B, Bloch J, Jan C,
Shin M, Conde F, Li XJ, Aebischer P,
Hantraye P, Deglon N (2007) Expression of
mutated huntingtin fragment in the putamen
is suffi cient to produce abnormal movement
in non-human primates. Mol Ther 15:
1444-1451
Search WWH ::




Custom Search